Elanco Animal Health Inc

elanco.com

Elanco Animal Health Inc (NYSE: ELAN) is an animal health company that develops and sells products for companion animals and farm animals. The filing excerpts provided do not contain sufficient detail to describe revenue streams, segment breakdown, product portfolio, geographic mix, or competitive position with the specificity required for a source-grounded description. All material claims would require inference beyond what the supplied excerpts support, so those details are omitted per source-grounding rules.

Peers: Catalent, Inc. Corcept Therapeutics Inc Harmony Biosciences Holdings Inc Intra-Cellular Therapies, Inc. Johnson & Johnson Organon & Co Royalty Pharma PLC Viatris Inc Zoetis Inc

Source: SEC 10-K, filed 2026-02-24

Dive deeper

Financial Snapshot

Revenue

TTM

$4.893B

Gross Margin

TTM

54.9%

Net Income

TTM

-$242.0M

Current Assets

2026 Q1

$3.584B

Current Liabilities

2026 Q1

$1.662B

Current Ratio

2026 Q1

215.64%

Total Assets

2026 Q1

$13.22B

Total Liabilities

2026 Q1

$6.722B

Book Value

2026 Q1

$6.500B

Cash

2026 Q1

$428.0M

P/E

Last 4 Quarters

N/A

Free Cash Flow

TTM

$315.0M

Stock Price

Market Cap: $12.396 Billion